Develops small molecule drugs to restore immune cell function for treating neurodegenerative and aging-related diseases.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Tranquis Therapeutics is a biopharmaceutical company focused on the discovery and development of therapies to treat neurodegenerative and aging-related diseases. The company develops small molecule drugs that target dysfunctional immune cells to restore mitochondrial and lysosomal function.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Tranquis Therapeutics Management Team
Investors
Hillsborough Venture
Remiges Ventures
SR One Ltd
Vivo Capital
Tranquis Therapeutics Valuations & Financials
View real-time NPM data on Tranquis Therapeutics stock including daily Tranquis Therapeutics stock price estimates, valuation history, and historical share price information. Access Tranquis Therapeutics financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Tranquis Therapeutics pricing across six independent market signals. Looking for private company due diligence data sources on Tranquis Therapeutics? Get in touch to learn more.
Similar Companies
like Tranquis Therapeutics
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Nalu Medical
Healthcare & Life Sciences
Offers a small, flexible, and adaptable neurostimulation system that delivers gentle electrical pulses to modulate chronic pain signals without implanted batteries.
Rupeek
Digital lending platform providing gold-backed loans with doorstep collection and secure storage through banking partners.
SWTCH Energy
Mobility & Transportation
Provides EV charging solutions for multi-tenant properties by leveraging existing grid infrastructure to maximize profitability and competitiveness.
Tmap Mobility
Provides comprehensive navigation and mobility services through an app offering route guidance, transit info, ride-hailing, and parking solutions.
UtiliData
Climate & Sustainability
Analyzes grid data to help utilities optimize energy distribution and improve power system reliability.
TravelPerk
Simplifies corporate travel by offering an all-in-one platform for booking, managing, and reporting trips with real-time options and expense tools.
Scuba
Enterprise Software
Analyzes user behavior and product interactions in real-time, enabling data-driven decisions and optimized user experiences.
Agtonomy
Embeds physical artificial intelligence into industrial equipment to execute routine off-road machinery tasks.
FAQ
We have answers
Tranquis Therapeutics stock does not trade on public stock exchanges. Tranquis Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Tranquis Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Tranquis Therapeutics Stock does not trade on public stock exchanges. In order to sell Tranquis Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Tranquis Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Tranquis Therapeutics share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Tranquis Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Tranquis Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Tranquis Therapeutics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Tranquis Therapeutics is a private company and has not had an IPO. There is currently no Tranquis Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Tranquis Therapeutics IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
